UDP-N-acetylgalactosamine → N-Acetyl-D-Galactosamine

HRID 716173

반응식

HRID 716173 반응식
[CH3:1][C:2]([NH:4][C@H:5]1[C@@H:10]([O:11]P(OP(OC[C@H]2O[C@@H](N3C(=O)NC(=O)C=C3)[C@H](O)[C@@H]2O)(O)=O)(O)=O)[O:9][C@H:8]([CH2:36][OH:37])[C@H:7]([OH:38])[C@@H:6]1[OH:39])=[O:3]>C(N(C(CO)(CO)CO)CCO)CO>[OH:11][CH:10]1[O:9][C@H:8]([CH2:36][OH:37])[C@H:7]([OH:38])[C@H:6]([OH:39])[C@H:5]1[NH:4][C:2]([CH3:1])=[O:3]

참가 물질

3

반응물 1

HCID 23700UDP-N-acetylgalactosamine

생성물 1

HCID 35717N-Acetyl-D-Galactosamine

시약·촉매·용매 1

HCID 81462Bistris용매

실험 절차

10 mcg of FGF-21 polypeptide (1 mg/ml) were incubated in 20 mM BisTris pH 6.7, 50 mM NaCl, 10 mM MnCl2 containing 10 molar equivalents (0.4 mM) of UDP-GalNAc and MBP-hGalNAcT2 (40 mU/mg) for 6 hours at 30° C.

후처리

  1. customfor 6 hours
  2. customat 30° C.

출처 및 근거

ORD 기록
ord-c79c645db2544fef96518aa6046bc6d5
출처 데이터셋
uspto-grants-2015_11
특허 번호
US09187532B2

연결된 노트

불러오는 중…